A 56-year-old man with type 2 diabetes, hypertension, and chronic kidney disease stage 3 is referred to a PMHNP by his primary care provider for management of newly diagnosed major depressive disorder. His PHQ-9 score is 16, and he reports low mood, fatigue, decreased interest in activities, and difficulty managing his diabetes regimen. His current medications include metformin, lisinopril, and amlodipine. His estimated GFR is 42 mL/min, and his most recent HbA1c is 8.9%, which has worsened over the past six months. The primary care provider requests collaborative treatment planning. Which of the following best represents the appropriate approach to integrated treatment planning for this patient?